antibiotic resistance
Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform
BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.
Day Zero Diagnostics Secures Additional $8.2M From CARB-X
The funding will support product development for Day Zero's whole-genome sequencing and machine learning-based diagnostic.
T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce
The firm is reducing its expenses by cutting 34 existing and 20 planned positions.
BioMérieux, Boehringer Ingelheim, Evotec Launch €40M AMR-Targeted Joint Venture
Called Aurobac Therapeutics, the joint venture will develop new antimicrobial drugs and companion diagnostics.
The company expects the trial results to bolster sales by increasing physician confidence in the panel.
Feb 11, 2022
Sep 7, 2021
May 7, 2021
Mar 23, 2021
Mar 15, 2021
Roche to Acquire GenMark Diagnostics for $1.8B
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Oct 23, 2020
Sep 30, 2020